首页> 外国专利> Composition for treatment of diabetes comprising sustained insulin analogue conjugate and sustained insulin secretory peptide conjugate

Composition for treatment of diabetes comprising sustained insulin analogue conjugate and sustained insulin secretory peptide conjugate

机译:包含持续胰岛素类似物结合物和持续胰岛素分泌肽结合物的糖尿病治疗组合物

摘要

The present invention relates to a pharmaceutical composition for preventing or treating diabetes comprising a continuous insulin analogue and a continuous insulin secretory peptide conjugate, and a method for treating diabetes, more specifically, the pharmaceutical composition comprises: Concomitant administration of a continuous analog conjugate and a continuous insulin secretory peptide conjugate suppresses weight gain associated with insulin administration, suppresses nausea and vomiting associated with insulin secretory peptide administration, lowers insulin dose, and compliance Can be greatly improved. The present invention also provides a pharmaceutical composition for improving pancreatic β-cell side effects in diabetic patients, comprising a long-acting insulin analog conjugate and a long-acting insulin-secreting peptide conjugate, and a step of administering the pharmaceutical composition In particular, there are side effects such as abnormal pancreatic β-cell function, pancreatic β-cell depletion, lipotoxicity, and glucotocity due to progression of diabetes. It is characterized by improving. [Selection] Figure 1
机译:本发明涉及一种用于预防或治疗糖尿病的包含连续胰岛素类似物和连续胰岛素分泌肽结合物的药物组合物,以及一种用于治疗糖尿病的方法,更具体地,该药物组合物包括:连续给药连续类似物结合物和药物。连续胰岛素分泌肽结合物可抑制与胰岛素给药相关的体重增加,抑制与胰岛素分泌肽给药相关的恶心和呕吐,降低胰岛素剂量,并可以大大改善依从性。本发明还提供了用于改善糖尿病患者的胰腺β细胞副作用的药物组合物,其包含长效胰岛素类似物缀合物和长效胰岛素分泌肽缀合物,以及给药该药物组合物的步骤。由于糖尿病的发展,会有一些副作用,例如胰岛β细胞功能异常,胰岛β细胞耗竭,脂质毒性和糖原性。它的特点是改进。 [选择]图1

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号